ATE49199T1 - 2-phenylalkyl-3-aminoalkyl-4(3h)-chinazolinonen verfahren zu deren herstellung, pharmazeutische zusammenstellungen und verwendung. - Google Patents

2-phenylalkyl-3-aminoalkyl-4(3h)-chinazolinonen verfahren zu deren herstellung, pharmazeutische zusammenstellungen und verwendung.

Info

Publication number
ATE49199T1
ATE49199T1 AT85109193T AT85109193T ATE49199T1 AT E49199 T1 ATE49199 T1 AT E49199T1 AT 85109193 T AT85109193 T AT 85109193T AT 85109193 T AT85109193 T AT 85109193T AT E49199 T1 ATE49199 T1 AT E49199T1
Authority
AT
Austria
Prior art keywords
group
carbon atoms
sub
sup
integer
Prior art date
Application number
AT85109193T
Other languages
English (en)
Inventor
Tetsuo Research Lab Mit Sekiya
Ltd Aza Furuki Oaza Wakagur Co
Mikio Research Lab Mit Tsutsui
Daijiro Research Lab Mit Horii
Akira Research Lab M Ishibashi
Original Assignee
Mitsubishi Chem Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Ind filed Critical Mitsubishi Chem Ind
Application granted granted Critical
Publication of ATE49199T1 publication Critical patent/ATE49199T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT85109193T 1984-07-26 1985-07-23 2-phenylalkyl-3-aminoalkyl-4(3h)-chinazolinonen verfahren zu deren herstellung, pharmazeutische zusammenstellungen und verwendung. ATE49199T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15408684A JPS6136273A (ja) 1984-07-26 1984-07-26 2−フエニルアルキル−4(3h)−キナゾリノン誘導体
EP85109193A EP0169537B1 (de) 1984-07-26 1985-07-23 2-Phenylalkyl-3-aminoalkyl-4(3H)-Chinazolinonen, Verfahren zu deren Herstellung, pharmazeutische Zusammenstellungen und Verwendung

Publications (1)

Publication Number Publication Date
ATE49199T1 true ATE49199T1 (de) 1990-01-15

Family

ID=15576584

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85109193T ATE49199T1 (de) 1984-07-26 1985-07-23 2-phenylalkyl-3-aminoalkyl-4(3h)-chinazolinonen verfahren zu deren herstellung, pharmazeutische zusammenstellungen und verwendung.

Country Status (9)

Country Link
US (1) US4668682A (de)
EP (1) EP0169537B1 (de)
JP (1) JPS6136273A (de)
KR (1) KR860001078A (de)
AT (1) ATE49199T1 (de)
CA (1) CA1266266A (de)
DE (1) DE3575132D1 (de)
DK (1) DK339685A (de)
HU (1) HU194836B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2037630C (en) * 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
GB9116207D0 (en) * 1991-07-26 1991-09-11 Ici Plc Novel compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
IT1266992B1 (it) * 1993-04-16 1997-01-24 Alfa Wassermann Spa Composti eterociclici, a struttura correlabile alle banzammidi, attivi nelle patologie gastro-intestinali, ad attivita' procinetica ed
US5756502A (en) * 1994-08-08 1998-05-26 Warner-Lambert Company Quinazolinone derivatives as cholyecystokinin (CCK) ligands
DE19501481A1 (de) * 1995-01-19 1996-07-25 Bayer Ag 2,8-Disubstituierte Chinazolinone
AU6837096A (en) * 1995-09-07 1997-03-27 Kissei Pharmaceutical Co. Ltd. 2-acylaminobenzamide derivatives and preventive and remedy for diseases caused by the supermultiplication of vascular intimal cells
DE69842109D1 (de) * 1997-08-21 2011-03-10 Shiseido Co Ltd Chinazolin-4-on Derivate, deren Herstellung und deren Verwendung als Haarwuchsmittel oder in äusserlich anzuwendenden Hautpflegemitteln
US6444816B1 (en) 1997-10-27 2002-09-03 Dr. Reddy's Research Foundation Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
US6337332B1 (en) * 1998-09-17 2002-01-08 Pfizer Inc. Neuropeptide Y receptor antagonists
US6890930B1 (en) 1999-09-28 2005-05-10 3-Dimensional Pharmaceuticals, Inc. Quinazolinones
CA2385921A1 (en) * 1999-09-28 2001-04-05 Merck Patent Gesellschaft Mit Beschraenkter Haftung Quinazolinones
US6967251B2 (en) * 2000-10-02 2005-11-22 Molecular Probes, Inc. Reagents for labeling biomolecules having aldehyde or ketone moieties
CA2444704C (en) * 2001-04-23 2012-07-10 University Of Virginia Patent Foundation Synthesis and evaluation of phthalimide mimics as anti-angiogenic agents
US7053216B2 (en) * 2001-11-19 2006-05-30 Iconix Pharmaceuticals, Inc. Modulators of Rho C activity
JP4384053B2 (ja) * 2002-12-13 2009-12-16 エフ.ホフマン−ラ ロシュ アーゲー 3h−キナゾリン−4−オン誘導体
KR100610731B1 (ko) * 2004-02-24 2006-08-09 한국과학기술연구원 T-형 칼슘 채널 차단제로서 유용한 3,4-디히드로퀴나졸린유도체 및 그의 제조 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2020234A1 (de) * 1970-04-25 1971-11-18 Cassella Farbwerke Mainkur Ag Basisch substituierte Derivate des 4(3H)-Chinazolinons

Also Published As

Publication number Publication date
KR860001078A (ko) 1986-02-22
DE3575132D1 (de) 1990-02-08
HUT39166A (en) 1986-08-28
HU194836B (en) 1988-03-28
US4668682A (en) 1987-05-26
EP0169537A2 (de) 1986-01-29
EP0169537B1 (de) 1990-01-03
EP0169537A3 (en) 1987-03-25
JPS6136273A (ja) 1986-02-20
DK339685D0 (da) 1985-07-25
CA1266266A (en) 1990-02-27
DK339685A (da) 1986-01-27

Similar Documents

Publication Publication Date Title
ATE49199T1 (de) 2-phenylalkyl-3-aminoalkyl-4(3h)-chinazolinonen verfahren zu deren herstellung, pharmazeutische zusammenstellungen und verwendung.
ES510402A0 (es) Un procedimiento para la preparacion de 1,-4dihidropiridinas.
ATE250622T1 (de) 4'-c-ethynyl-pyrimidine nukleoside
DK57281A (da) Fremgangsmaade til fremstilling af substituerede imidazolderivater eller syreadditionssalte deraf
ES8801245A1 (es) Un procedimiento para preparar derivados de piperidina
ES8307760A1 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
ES534505A0 (es) Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina
ATE66674T1 (de) Dihydropyridin-derivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zusammensetzungen, und verfahren zur herstellung dieser zusammensetzungen.
ATE72447T1 (de) Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung.
MY102921A (en) Amino-alcohol derivatives and processes for their preparation.
ATE23995T1 (de) Pyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE41659T1 (de) Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
IL75165A (en) Dihydropyridines and pharmaceutical compositions containing them
DE69007356D1 (de) Zyklisches Tetrapeptid und Verfahren zu dessen Herstellung.
ATE27455T1 (de) Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
PH25352A (en) Tetraoxo compounds, pharmaceutical compostions
DK162785D0 (da) 1-cyklohexyl-3,4-dihydroisoquinolinderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende dem
ES485333A1 (es) Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales
EP0218195A3 (de) Bis-(Dibenzo[b,d]pyranyloxy)-propane

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties